{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:41:36Z","timestamp":1790487696266,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI-15614"],"award-info":[{"award-number":["AI-15614"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HL126736"],"award-info":[{"award-number":["HL126736"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["ES025534"],"award-info":[{"award-number":["ES025534"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HL135872-01"],"award-info":[{"award-number":["HL135872-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010279","name":"Interleukin Foundation for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010279","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1038\/s41590-019-0467-1","type":"journal-article","created":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T16:02:55Z","timestamp":1566230575000},"page":"1138-1149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["IL-1R3 blockade broadly attenuates the functions of six members of the IL-1 family, revealing their contribution to models of disease"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2629-5391","authenticated-orcid":false,"given":"Jesper Falkesgaard","family":"H\u00f8jen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Louise Vindvad","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S.","family":"McKee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan Taylor","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Azam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars P.","family":"Lunding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis M.","family":"de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Swartzwelter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wegmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7020-5173","authenticated-orcid":false,"given":"Martin","family":"Tolstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Beckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayumi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5073-8316","authenticated-orcid":false,"given":"Charles A.","family":"Dinarello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,19]]},"reference":[{"key":"467_CR1","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrd2805","volume":"9","author":"M Kopf","year":"2010","unstructured":"Kopf, M., Bachmann, M. F. & Marsland, B. J. Averting inflammation by targeting the cytokine environment. Nat. Rev. Drug Discovery 9, 703\u2013718 (2010).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"467_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1165\/rcmb.2004-0309OC","volume":"32","author":"U Lappalainen","year":"2005","unstructured":"Lappalainen, U., Whitsett, J. A., Wert, S. E., Tichelaar, J. W. & Bry, K. Interleukin-1\u03b2 causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am. J.Respir. Cell Mol. Biol. 32, 311\u2013318 (2005).","journal-title":"Am. J.Respir. Cell Mol. Biol."},{"key":"467_CR3","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.4049\/jimmunol.0802387","volume":"183","author":"D Prefontaine","year":"2009","unstructured":"Prefontaine, D. et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J. Immunol. 183, 5094\u20135103 (2009).","journal-title":"J. Immunol."},{"key":"467_CR4","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.coph.2012.02.009","volume":"12","author":"JE Towne","year":"2012","unstructured":"Towne, J. E. & Sims, J. E. IL-36 in psoriasis. Curr. Opin. Pharmacol. 12, 486\u2013490 (2012).","journal-title":"Curr. Opin. Pharmacol."},{"key":"467_CR5","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1172\/JCI63451","volume":"122","author":"L Tortola","year":"2012","unstructured":"Tortola, L. et al. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J. Clin. Invest. 122, 3965\u20133976 (2012).","journal-title":"J. Clin. Invest."},{"key":"467_CR6","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","volume":"39","author":"C Garlanda","year":"2013","unstructured":"Garlanda, C., Dinarello, C. A. & Mantovani, A. The interleukin-1 family: back to the future. Immunity 39, 1003\u20131018 (2013).","journal-title":"Immunity"},{"key":"467_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.smim.2013.10.023","volume":"25","author":"D Boraschi","year":"2013","unstructured":"Boraschi, D. & Tagliabue, A. The interleukin-1 receptor family. Semin. Immunol. 25, 394\u2013407 (2013).","journal-title":"Semin. Immunol."},{"key":"467_CR8","doi-asserted-by":"publisher","first-page":"7727","DOI":"10.1074\/jbc.272.12.7727","volume":"272","author":"H Wesche","year":"1997","unstructured":"Wesche, H. et al. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J. Biol. Chem. 272, 7727\u20137731 (1997).","journal-title":"J. Biol. Chem."},{"key":"467_CR9","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/eji.1830270139","volume":"27","author":"C Korherr","year":"1997","unstructured":"Korherr, C., Hofmeister, R., Wesche, H. & Falk, W. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling. Eur. J. Immunol. 27, 262\u2013267 (1997).","journal-title":"Eur. J. Immunol."},{"key":"467_CR10","doi-asserted-by":"publisher","first-page":"12161","DOI":"10.1128\/JVI.75.24.12161-12168.2001","volume":"75","author":"M Hezareh","year":"2001","unstructured":"Hezareh, M., Hessell, A. J., Jensen, R. C., van de Winkel, J. G. & Parren, P. W. Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1. J. Virol. 75, 12161\u201312168 (2001).","journal-title":"J. Virol."},{"key":"467_CR11","doi-asserted-by":"publisher","first-page":"896","DOI":"10.4161\/mabs.26436","volume":"5","author":"MK Leabman","year":"2013","unstructured":"Leabman, M. K. et al. Effects of altered FcgammaR binding on antibody pharmacokinetics in cynomolgus monkeys. MAbs 5, 896\u2013903 (2013).","journal-title":"MAbs"},{"key":"467_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrd3003","volume":"9","author":"TT Hansel","year":"2010","unstructured":"Hansel, T. T., Kropshofer, H., Singer, T., Mitchell, J. A. & George, A. J. The safety and side effects of monoclonal antibodies. Nat. Rev. Drug Discovery 9, 325\u2013338 (2010).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"467_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1182\/blood-2014-05-552729","volume":"124","author":"DW Lee","year":"2014","unstructured":"Lee, D. W. et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood 124, 188\u2013195 (2014).","journal-title":"Blood"},{"key":"467_CR14","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S1074-7613(02)00514-9","volume":"18","author":"DE Smith","year":"2003","unstructured":"Smith, D. E. et al. The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. Immunity 18, 87\u201396 (2003).","journal-title":"Immunity"},{"key":"467_CR15","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cell.2016.10.018","volume":"167","author":"R Ter Horst","year":"2016","unstructured":"Ter Horst, R. et al. Host and environmental factors influencing individual human cytokine responses. Cell 167, 1111\u20131124 e1113 (2016).","journal-title":"Cell"},{"key":"467_CR16","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1084\/jem.20021787","volume":"197","author":"BN Gantner","year":"2003","unstructured":"Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S. & Underhill, D. M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197, 1107\u20131117 (2003).","journal-title":"J. Exp. Med."},{"key":"467_CR17","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1086\/523110","volume":"196","author":"NA Gow","year":"2007","unstructured":"Gow, N. A. et al. Immune recognition of Candida albicans beta-glucan by dectin-1. J. Infect. Dis. 196, 1565\u20131571 (2007).","journal-title":"J. Infect. Dis."},{"key":"467_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"F Martinon","year":"2006","unstructured":"Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237\u2013241 (2006).","journal-title":"Nature"},{"key":"467_CR19","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/ar2952","volume":"12","author":"N Busso","year":"2010","unstructured":"Busso, N. & So, A. Mechanisms of inflammation in gout. Arthritis Res. Ther. 12, 206 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"467_CR20","doi-asserted-by":"publisher","first-page":"3237","DOI":"10.1002\/art.27667","volume":"62","author":"LA Joosten","year":"2010","unstructured":"Joosten, L. A. et al. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1beta production via the ASC\/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 62, 3237\u20133248 (2010).","journal-title":"Arthritis Rheum."},{"key":"467_CR21","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/nri1841","volume":"6","author":"CT Pham","year":"2006","unstructured":"Pham, C. T. Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. Immunol. 6, 541\u2013550 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"467_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1006\/cimm.1995.1183","volume":"165","author":"K Kakimoto","year":"1995","unstructured":"Kakimoto, K., Matsukawa, A., Yoshinaga, M. & Nakamura, H. Suppressive effect of a neutrophil elastase inhibitor on the development of collagen-induced arthritis. Cell Immunol. 165, 26\u201332 (1995).","journal-title":"Cell Immunol"},{"key":"467_CR23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3109\/01902148.2013.870261","volume":"40","author":"HY Lee","year":"2014","unstructured":"Lee, H. Y. et al. Blockade of IL-33\/ST2 ameliorates airway inflammation in a murine model of allergic asthma. Exp. Lung Res. 40, 66\u201376 (2014).","journal-title":"Exp. Lung Res."},{"key":"467_CR24","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1056\/NEJMoa1013068","volume":"365","author":"S Marrakchi","year":"2011","unstructured":"Marrakchi, S. et al. Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N. Engl J. Med. 365, 620\u2013628 (2011).","journal-title":"N. Engl J. Med."},{"key":"467_CR25","doi-asserted-by":"publisher","first-page":"e1043","DOI":"10.1542\/peds.2012-3935","volume":"132","author":"L Rossi-Semerano","year":"2013","unstructured":"Rossi-Semerano, L. et al. First clinical description of an infant with interleukin-36-receptor antagonist deficiency successfully treated with anakinra. Pediatrics 132, e1043\u2013e1047 (2013).","journal-title":"Pediatrics"},{"key":"467_CR26","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1002\/eji.201343801","volume":"43","author":"B Flutter","year":"2013","unstructured":"Flutter, B. & Nestle, F. O. TLRs to cytokines: mechanistic insights from the imiquimod mouse model of psoriasis. Eur. J. Immunol. 43, 3138\u20133146 (2013).","journal-title":"Eur. J. Immunol."},{"key":"467_CR27","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1161\/ATVBAHA.108.179705","volume":"32","author":"P Libby","year":"2012","unstructured":"Libby, P. Inflammation in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32, 2045\u20132051 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"467_CR28","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883\u2013899 (2010).","journal-title":"Cell"},{"key":"467_CR29","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1093\/brain\/awv231","volume":"138","author":"VK Ramanan","year":"2015","unstructured":"Ramanan, V. K. et al. GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer\u2019s disease implicates microglial activation gene IL1RAP. Brain 138, 3076\u20133088 (2015).","journal-title":"Brain"},{"key":"467_CR30","doi-asserted-by":"publisher","first-page":"16280","DOI":"10.1073\/pnas.1004408107","volume":"107","author":"M Jaras","year":"2010","unstructured":"Jaras, M. et al. Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein. Proc. Natl Acad. Sci. USA 107, 16280\u201316285 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"467_CR31","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","volume":"377","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl J. Med. 377, 1119\u20131131 (2017).","journal-title":"N. Engl J. Med."},{"key":"467_CR32","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/S0140-6736(17)32247-X","volume":"390","author":"PM Ridker","year":"2017","unstructured":"Ridker, P. M. et al. Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet 390, 1833\u20131842 (2017).","journal-title":"Lancet"},{"key":"467_CR33","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/cmi.2016.34","volume":"14","author":"D Bertheloot","year":"2017","unstructured":"Bertheloot, D. & Latz, E. HMGB1, IL-1alpha, IL-33 and S100 proteins: dual-function alarmins. Cell Mol. Immunol. 14, 43\u201364 (2017).","journal-title":"Cell Mol. Immunol."},{"key":"467_CR34","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1002\/eji.201041360","volume":"41","author":"AJ Hueber","year":"2011","unstructured":"Hueber, A. J. et al. IL-33 induces skin inflammation with mast cell and neutrophil activation. Eur. J. Immunol. 41, 2229\u20132237 (2011).","journal-title":"Eur. J. Immunol."},{"key":"467_CR35","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/blood-2012-05-434209","volume":"121","author":"M Enoksson","year":"2013","unstructured":"Enoksson, M. et al. Intraperitoneal influx of neutrophils in response to IL-33 is mast cell-dependent. Blood 121, 530\u2013536 (2013).","journal-title":"Blood"},{"key":"467_CR36","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/j.immuni.2015.06.003","volume":"42","author":"IS Afonina","year":"2015","unstructured":"Afonina, I. S., Muller, C., Martin, S. J. & Beyaert, R. Proteolytic processing of interleukin-1 family cytokines: Variations on a common theme. Immunity 42, 991\u20131004 (2015).","journal-title":"Immunity"},{"key":"467_CR37","doi-asserted-by":"publisher","first-page":"3642","DOI":"10.1002\/art.24959","volume":"60","author":"M Guma","year":"2009","unstructured":"Guma, M. et al. Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation. Arthritis Rheum. 60, 3642\u20133650 (2009).","journal-title":"Arthritis Rheum."},{"key":"467_CR38","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/intimm\/dxg054","volume":"15","author":"S Nakae","year":"2003","unstructured":"Nakae, S. et al. IL-1 is required for allergen-specific Th2 cell activation and the development of airway hypersensitivity response. Int. Immunol. 15, 483\u2013490 (2003).","journal-title":"Int. Immunol."},{"key":"467_CR39","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1002\/eji.201445215","volume":"45","author":"H Rabeony","year":"2015","unstructured":"Rabeony, H. et al. IMQ-induced skin inflammation in mice is dependent on IL-1R1 and MyD88 signaling but independent of the NLRP3 inflammasome. Eur. J. Immunol. 45, 2847\u20132857 (2015).","journal-title":"Eur. J. Immunol."},{"key":"467_CR40","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fphar.2013.00046","volume":"4","author":"SS Possa","year":"2013","unstructured":"Possa, S. S., Leick, E. A., Prado, C. M., Martins, M. A. & Tiberio, I. F. Eosinophilic inflammation in allergic asthma. Front. Pharmacol. 4, 46 (2013).","journal-title":"Front. Pharmacol."},{"key":"467_CR41","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/cea.12283","volume":"44","author":"T Tanabe","year":"2014","unstructured":"Tanabe, T., Shimokawaji, T., Kanoh, S. & Rubin, B. K. IL-33 stimulates CXCL8\/IL-8 secretion in goblet cells but not normally differentiated airway cells. Clin. Exp. Allergy 44, 540\u2013552 (2014).","journal-title":"Clin. Exp. Allergy"},{"key":"467_CR42","doi-asserted-by":"publisher","first-page":"6756138","DOI":"10.1155\/2016\/6756138","volume":"2016","author":"P Alvarez","year":"2016","unstructured":"Alvarez, P. & Jensen, L. E. Imiquimod treatment causes systemic disease in mice resembling generalized pustular psoriasis in an IL-1 and IL-36 dependent manner. Mediators Inflamm. 2016, 6756138 (2016).","journal-title":"Mediators Inflamm."},{"key":"467_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/000155599750011606","volume":"79","author":"M Sticherling","year":"1999","unstructured":"Sticherling, M., Sautier, W., Schroder, J. M. & Christophers, E. Interleukin-8 plays its role at local level in psoriasis vulgaris. Acta Derm. Venereol. 79, 4\u20138 (1999).","journal-title":"Acta Derm. Venereol."},{"key":"467_CR44","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","volume":"140","author":"JE Hawkes","year":"2017","unstructured":"Hawkes, J. E., Chan, T. C. & Krueger, J. G. Psoriasis pathogenesis and the development of novel targeted immune therapies. J. Allergy Clin. Immunol. 140, 645\u2013653 (2017).","journal-title":"J. Allergy Clin. Immunol."},{"key":"467_CR45","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jaci.2015.01.033","volume":"136","author":"S Mashiko","year":"2015","unstructured":"Mashiko, S. et al. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. J. Allergy Clin. Immunol. 136, 351\u2013359 e351 (2015).","journal-title":"J. Allergy Clin. Immunol."},{"key":"467_CR46","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1084\/jem.188.10.1955","volume":"188","author":"UA Betz","year":"1998","unstructured":"Betz, U. A. et al. Postnatally induced inactivation of gp130 in mice results in neurological, cardiac, hematopoietic, immunological, hepatic, and pulmonary defects. J. Exp. Med. 188, 1955\u20131965 (1998).","journal-title":"J. Exp. Med."},{"key":"467_CR47","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/1074-7613(95)90047-0","volume":"2","author":"X Cao","year":"1995","unstructured":"Cao, X. et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2, 223\u2013238 (1995).","journal-title":"Immunity"},{"key":"467_CR48","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.4049\/jimmunol.161.10.5614","volume":"161","author":"EB Cullinan","year":"1998","unstructured":"Cullinan, E. B. et al. IL-1 receptor accessory protein is an essential component of the IL-1 receptor. J. Immunol. 161, 5614\u20135620 (1998).","journal-title":"J. Immunol."},{"key":"467_CR49","first-page":"1431","volume":"3","author":"N Dyballa","year":"2009","unstructured":"Dyballa, N. & Metzger, S. Fast and sensitive colloidal coomassie G-250 staining for proteins in polyacrylamide gels. J. Vis. Exp. 3, 1431 (2009).","journal-title":"J. Vis. Exp."},{"key":"467_CR50","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/SHK.0000000000000245","volume":"43","author":"HB Moore","year":"2015","unstructured":"Moore, H. B. et al. Hemolysis exacerbates hyperfibrinolysis, whereas platelolysis shuts down fibrinolysis: evolving concepts of the spectrum of fibrinolysis in response to severe injury. Shock 43, 39\u201346 (2015).","journal-title":"Shock"},{"key":"467_CR51","first-page":"762","volume":"5","author":"FL van de Veerdonk","year":"2014","unstructured":"van de Veerdonk, F. L. et al. Protective host defense against disseminated candidiasis is impaired in mice expressing human interleukin-37. Front. Microbiol. 5, 762 (2014).","journal-title":"Front. Microbiol."},{"key":"467_CR52","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/mi.2015.14","volume":"8","author":"AS McKee","year":"2015","unstructured":"McKee, A. S., Mack, D. G., Crawford, F. & Fontenot, A. P. MyD88 dependence of beryllium-induced dendritic cell trafficking and CD4(+) T-cell priming. Mucosal Immunol. 8, 1237\u20131247 (2015).","journal-title":"Mucosal Immunol."},{"key":"467_CR53","doi-asserted-by":"publisher","first-page":"5615","DOI":"10.4049\/jimmunol.1402529","volume":"194","author":"LP Lunding","year":"2015","unstructured":"Lunding, L. P. et al. Poly(inosinic-cytidylic) acid-triggered exacerbation of experimental asthma depends on IL-17A produced by NK cells. J. Immunol. 194, 5615\u20135625 (2015).","journal-title":"J. Immunol."},{"key":"467_CR54","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s004280050160","volume":"432","author":"H Fehrenbach","year":"1998","unstructured":"Fehrenbach, H. et al. Ultrastructural pathology of the alveolar type II pneumocytes of human donor lungs. Electron microscopy, stereology, and microanalysis. Virchows Arch. 432, 229\u2013239 (1998).","journal-title":"Virchows Arch."},{"key":"467_CR55","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1365-2818.1990.tb03036.x","volume":"159","author":"T Mattfeldt","year":"1990","unstructured":"Mattfeldt, T., Mall, G., Gharehbaghi, H. & Moller, P. Estimation of surface area and length with the orientator. J. Microsc. 159, 301\u2013317 (1990).","journal-title":"J. Microsc."}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41590-019-0467-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41590-019-0467-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41590-019-0467-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T07:17:25Z","timestamp":1695107845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-019-0467-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,19]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["467"],"URL":"https:\/\/doi.org\/10.1038\/s41590-019-0467-1","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,19]]},"assertion":[{"value":"1 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.B. is employed by MAB Discovery GmbH, Neuried, Germany. S.F. is the CEO of MAB Discovery GmbH. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}